ArticleFrontiers in medicine2025

Protein kinase C zeta promotes thyroid Cancer progression and represents a novel therapeutic target: evidence from specific atypical PKC inhibitor 2-acetyl-1,3-cyclopentanedione inhibitor studies.

Jian Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.